查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595317

医药中间体市场：按类型、应用和最终用户划分 - 全球预测 2025-2030

Pharmaceutical Intermediates Market by Type (GMP, Non GMP), Application (Analgesics, Antibiotics, Antipyretic), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医药中间体市场价值为314.4亿美元，预计2024年将达到339.9亿美元，复合年增长率为8.19%，到2030年将达到545.5亿美元。

医药中间体市场广阔，涵盖合成活性药物成分 (API) 所必需的化合物。这些中间体充当可管理且高效的药物製造过程的化学前体。对药物中间体的需求源于对创新药物和治疗方法不断增长的需求，推动了新的给药途径和製剂的持续开发。这些中间体主要用于药品製造，在肿瘤、心血管疾病和感染疾病等治疗领域有广泛的应用。最终用途广泛，包括製药商、契约製造组织和研究机构。市场成长是由製药业扩张、技术进步以及研发投资增加等因素所推动的。对具有成本效益、高品质的药品製造的需求正在推动契约製造和专业承包商扩大其服务。此外，生技药品和生物相似药的兴起以及新兴市场对医疗保健基础设施的投资提供了一条成长之路。儘管形势乐观，但挑战包括严格的监管要求使核准流程复杂化以及全球分销管道的差异影响及时进入市场。此外，在遵守高品质标准的同时保持成本效益仍然是一个限制。一个合适的创新领域是开发可持续生产中间体的绿色化学工艺，同时解决经济和环境问题。此外，中间研究中高通量筛检技术的扩展有可能加快药物发现时间。透过技术进步毒害新兴市场并促进资源优化的策略伙伴关係可能会提高市场渗透率。市场的本质是动态和竞争的，其特点是强有力的监管监督和不断发展的全球标准，而技术创新和不断扩大的医疗保健需求提供了巨大的商机。这些见解要求相关人员专注于永续实践和适应性强的业务策略，以有效利用成长潜力。

主要市场统计
基准年[2023] 314.4亿美元
预测年份 [2024] 339.9亿美元
预测年份 [2030] 545.5亿美元
复合年增长率（%） 8.19%

市场动态：揭示快速发展的医药中间体市场的关键市场洞察

医药中间体市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和生活方式相关疾病增加
    • 各药厂资金筹措快速增加
    • 临床研究中较采用医药中间体
  • 市场限制因素
    • 与活性药物成分相关的副作用
  • 市场机会
    • 製药业正在进行的研究和开发活动
    • 策略联盟投资与产能扩张
  • 市场挑战
    • 有关药品行销的严格规则和规定

波特五力：驾驭医药中间体市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对医药中间体市场的影响

外部宏观环境因素对医药中间体市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医药中间体市场竞争状况

对医药中间体市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵医药中间体市场供应商绩效评估

FPNV定位矩阵是评估医药中间体市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘医药中间体市场的成功之路

医药中间体市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和文明病增加
      • 各药厂资金筹措快速增加
      • 临床研究中较采用医药中间体
    • 抑制因素
      • 与活性药物成分相关的副作用
    • 机会
      • 製药业的持续研发活动
      • 策略联盟和投资以扩大产能
    • 任务
      • 严格的药品上市规则和规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章医药中间体市场：依类型

  • 品管标准
  • 非GMP

第七章医药中间体市场：依应用分类

  • 止痛药
  • 抗生素
  • 退烧剂
  • 维他命

第八章医药中间体市场：依最终用户分类

  • 契约製造组织
  • 製药公司
  • 研究室

第九章美洲医药中间体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太医药中间体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲医药中间体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aceto Corporation
  • AGC Group
  • BASF SE
  • Codexis, Inc.
  • Cycle Pharma
  • Dishman Group
  • Easter Chemical Corporation
  • Life Sciences Private Limited
  • Nectar Lifesciences Limited
  • Noah Chemicals
  • Proviron Holding NV
  • Sanofi SA
  • SAREX
  • Vertellus Holdings LLC
  • ZCL Chemicals Ltd.
Product Code: MRR-030EE48515E9

The Pharmaceutical Intermediates Market was valued at USD 31.44 billion in 2023, expected to reach USD 33.99 billion in 2024, and is projected to grow at a CAGR of 8.19%, to USD 54.55 billion by 2030.

The market for pharmaceutical intermediates is broad, encompassing compounds crucial in synthesizing active pharmaceutical ingredients (APIs). These intermediates serve as the chemical precursors to manageable and efficient drug manufacturing processes. The need for pharmaceutical intermediates arises from the increasing demand for innovative drugs and therapies, driving the continuous development of new medication routes and formulations. Primarily utilized in drug manufacturing, these intermediates find extensive application in therapeutic areas like oncology, cardiovascular diseases, and infectious diseases. Their end-use spans pharmaceutical manufacturers, contract manufacturing organizations, and research institutes. Market growth is bolstered by factors such as the expanding pharmaceutical industry, technological advancements, and increasing R&D investments. The demand for cost-efficient and quality pharmaceutical manufacturing catalyzes opportunities for contract manufacturers and specialized suppliers to expand services. Additionally, the rise of biologics and biosimilars presents a growth avenue, alongside the emerging markets investing in healthcare infrastructure. Despite the promising landscape, challenges include stringent regulatory requirements, which complicate the approval process and discrepancies in global distribution channels affecting timely market access. Furthermore, maintaining cost-effectiveness while adhering to high-quality standards remains a limitation. A pertinent area for innovation is the development of green chemistry processes to produce intermediates sustainably, which would address both economic and environmental considerations. Also, expanding high-throughput screening techniques in intermediate research could accelerate drug discovery timelines. Poisoning emerging markets with technological advancements and fostering strategic partnerships for resource optimization would enhance market penetration. The nature of the market is dynamic and competitive, with substantial opportunities driven by technological innovations and expanding healthcare needs, yet characterized by rigorous regulatory scrutiny and evolving global standards. These insights mandate stakeholders to focus on sustainable practices and adaptable business strategies to harness potential growth effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 31.44 billion
Estimated Year [2024] USD 33.99 billion
Forecast Year [2030] USD 54.55 billion
CAGR (%) 8.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of chronic and lifestyle-driven diseases
    • Surge in the funding by various drug-making companies
    • Rising adoption of pharmaceutical intermediates in clinical research
  • Market Restraints
    • Side effects related to the active pharmaceutical ingredients
  • Market Opportunities
    • Ongoing research and development activities in the pharmaceutical industry
    • Strategic alliances and investment for capacity expansion
  • Market Challenges
    • Strict rules and regulations to launch pharmaceutical drugs

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Intermediates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Intermediates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Intermediates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Intermediates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Intermediates Market

A detailed market share analysis in the Pharmaceutical Intermediates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Intermediates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Intermediates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Intermediates Market

A strategic analysis of the Pharmaceutical Intermediates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aceto Corporation, AGC Group, BASF SE, Codexis, Inc., Cycle Pharma, Dishman Group, Easter Chemical Corporation, Life Sciences Private Limited, Nectar Lifesciences Limited, Noah Chemicals, Proviron Holding NV, Sanofi S.A., SAREX, Vertellus Holdings LLC, and ZCL Chemicals Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across GMP and Non GMP.
  • Based on Application, market is studied across Analgesics, Antibiotics, Antipyretic, and Vitamins.
  • Based on End-User, market is studied across Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of chronic and lifestyle-driven diseases
      • 5.1.1.2. Surge in the funding by various drug-making companies
      • 5.1.1.3. Rising adoption of pharmaceutical intermediates in clinical research
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects related to the active pharmaceutical ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities in the pharmaceutical industry
      • 5.1.3.2. Strategic alliances and investment for capacity expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Strict rules and regulations to launch pharmaceutical drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. GMP
  • 6.3. Non GMP

7. Pharmaceutical Intermediates Market, by Application

  • 7.1. Introduction
  • 7.2. Analgesics
  • 7.3. Antibiotics
  • 7.4. Antipyretic
  • 7.5. Vitamins

8. Pharmaceutical Intermediates Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Manufacturing Organizations
  • 8.3. Pharmaceutical Companies
  • 8.4. Research Labs

9. Americas Pharmaceutical Intermediates Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Intermediates Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Intermediates Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aceto Corporation
  • 2. AGC Group
  • 3. BASF SE
  • 4. Codexis, Inc.
  • 5. Cycle Pharma
  • 6. Dishman Group
  • 7. Easter Chemical Corporation
  • 8. Life Sciences Private Limited
  • 9. Nectar Lifesciences Limited
  • 10. Noah Chemicals
  • 11. Proviron Holding NV
  • 12. Sanofi S.A.
  • 13. SAREX
  • 14. Vertellus Holdings LLC
  • 15. ZCL Chemicals Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL INTERMEDIATES MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY GMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY NON GMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIPYRETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023